Previous 10 | Next 10 |
AnPac Bio-Medical Science (ANPC) +29% on launching novel Cancer treatment technology and product JV.Pieris Pharmaceuticals (PIRS) +21% on collaboration with Genentech.Ault Global Holdings (DPW) +14% on Q1 results.Taiwan Liposome Company (TLC) +13% as its application for Am...
HAIFA, Israel, May 25, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc . (Nasdaq:PSTI) (TASE:PSTI) (the “Company”), a leading biotechnology company, today announced the receipt of a “Disbursement Offer” in the amount of €20 million (approximate...
Political change along with updated White House priorities have certainly created a need to review investment portfolios. As the national focus shifts from one area of fulfilling citizens' wants and needs to another, some industries are getting more attention while others are put on “hi...
"If you own the turbo-charged growth stocks... you either need to steel yourself for the pain or cut your losses on the next sharp move up, because we're in a new market that’s very different from last year," Jim Cramer said in the latest episode of Mad Money. "What worked in 2020 hasn...
Pluristem Therapeutics (PSTI) reports positive topline results from Phase I study evaluating the safety and exploratory efficacy of PLX-R18 in subjects with incomplete hematopoietic recovery following Hematopoietic Cell Transplantation ((HCT)).PLX-R18 was well-tolerated with a favorable safet...
Galera Therapeutics (GRTX) +41% on updating data from pancreatic cancer trial.Willamette Valley Vineyards (WVVI) +18%.Nokia Corporation (NOK) +17% on Q1 results.VEREIT (VER) +17% as Realty Income to acquire the company.Enlivex Therapeutics (ENLV) +13%.Pluristem Therapeutics (PS...
New therapy has potential to generate improved blood counts in all three blood cell lineages, a meaningful advantage over existing treatments The company will conduct an analyst and investor call on May 3, 2021, at 10am EDT HAIFA, Israel, April 29, 2021 (GLOBE NEWSWIRE) -- P...
Longeveron has filed proposed terms for a $25 million IPO. The firm is developing a treatment for Alzheimer's Disease and other age-related conditions. LGVN is thinly capitalized and has scant chance of an AD treatment where major pharmas have failed, so I'll pass on the IPO. ...
Pluristem Therapeutics (PSTI) traded 1.5% down in premarket trade after entering into definitive agreements with institutional investors for the purchase and sale of 4.76M shares at $6.30/share in a registered direct offering, for gross proceeds of $30M.Offer close is expected ...
HAIFA, Israel, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological therapeutic products (“Pluristem” or the “Company”), today annou...
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...